Stock listing
688136 Stock Price, News, Filings & Events — Kexing Biopharm Co., Ltd. Class A
Selected listing: 688136 · SSE · CNY · CN
This page tracks Kexing Biopharm Co., Ltd. Class A's 688136:SSE listing on SSE in CNY for CN, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 688136:SSE. 688136:SSE is the stock-level entry point for investors researching Kexing Biopharm Co., Ltd. Class A, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Kexing Biopharm Co., Ltd. Class A is a publicly traded company on the Chinese market, with a market capitalization of approximately 597.86 million USD. The company focuses on biopharmaceuticals and aims to contribute to advancements in healthcare. Kexing Biopharm is identified by its ticker symbol 688136.

- Ticker
- 688136:SSE
- Asset type
- Stock
- Market cap
- $700.0M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- SSE
- Currency
- CNY
Kexing Biopharm Co., Ltd. Class A 688136:SSE stock context
This page tracks Kexing Biopharm Co., Ltd. Class A's 688136:SSE listing on SSE in CNY for CN, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 688136:SSE. 688136:SSE is the stock-level entry point for investors researching Kexing Biopharm Co., Ltd. Class A, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Kexing Biopharm Co., Ltd. Class A is a publicly traded company on the Chinese market, with a market capitalization of approximately 597.86 million USD. The company focuses on biopharmaceuticals and aims to contribute to advancements in healthcare. Kexing Biopharm is identified by its ticker symbol 688136.
Latest news from Kexing Biopharm Co., Ltd. Class A
Kexing Biopharm's Investigational Anti-TL1A Monoclonal Antibody GB20 Cleared for Clinical Trials in China
October 4, 2026
"SHAN DONG KEXING BIOPRODUCTS CO., LTD."Announcement on Voluntary Disclosure of Receipt of the Clinical Trial Approval Notice for GB20 Injection
September 21, 2026
"SHAN DONG KEXING BIOPRODUCTS CO., LTD."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry
September 7, 2026
"SHAN DONG KEXING BIOPRODUCTS CO., LTD."Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026
August 21, 2026
"SHAN DONG KEXING BIOPRODUCTS CO., LTD."Announcement on Change of Sponsor Representative for Continuous Supervision
August 7, 2026
Research Kexing Biopharm Co., Ltd. Class A
Kexing Biopharm Co., Ltd. Class A investor report
Review AI stock analysis and investor report context for 688136:SSE.
Kexing Biopharm Co., Ltd. Class A company profile
View the public company page for Kexing Biopharm Co., Ltd. Class A on 6ix.
Kexing Biopharm Co., Ltd. Class A news
Read company news and market updates connected to Kexing Biopharm Co., Ltd. Class A.
Kexing Biopharm Co., Ltd. Class A investor events
Find investor webinars, events, and replay context for Kexing Biopharm Co., Ltd. Class A.